{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:02:07Z","timestamp":1763535727592,"version":"3.37.3"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation in China","doi-asserted-by":"publisher","award":["81771413","81801299"],"award-info":[{"award-number":["81771413","81801299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology","doi-asserted-by":"publisher","award":["KM201910025019"],"award-info":[{"award-number":["KM201910025019"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2020,10,13]]},"abstract":"<jats:sec>\n<jats:title>Backgrounds:<\/jats:title>\n<jats:p>Due to the recent development of non-invasive examinations, more asymptomatic\npatients with Moyamoya Disease (MMD) have been diagnosed than ever. However, its underlying\nmolecular mechanisms and clinical intervention guidelines are all still obscure.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Microarray was used to explore those differentially expressed mRNAs and lncRNAs in peripheral\nneutrophils of asymptomatic MMD patients. Then enrichment analyses based on Gene Ontology\n(GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) for those differentially expressed\nmRNAs and lncRNA associated mRNAs were performed for underlying molecular mechanisms.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Here, we identified a total of 2824 differentially expressed lncRNAs and 522 differentially\nexpressed mRNAs (fold change &gt; 2 and P&lt;0.05) in peripheral neutrophils of asymptomatic MMD patients,\ncompared with healthy controls. Then enrichment analyses based on GO and KEGG showed\nthat the neighboring protein-coding mRNAs of those up-regulated and down-regulated lncRNAs were\nmainly involved in distinct metabolic processes respectively, which may act as a complementary response\nto insufficient blood supplies in MMD. Further enrichment analyses of those differentially expressed\nmRNAs preferentially listed essential physiological processes such as peptide cross-linking,\nchromatin assembly among others. Moreover, altered mRNAs also revealed to be enriched in renin secretion,\nplatelet activation, inflammation and others.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We demonstrated for the first time that metabolic adjustments by dysregulated lncRNAs\nin peripheral neutrophils might partially account for the complete compensation of asymptomatic\nMMD patients. In addition, more attention should be paid on renin secretion and platelet activation in\norder to better understand the pathogenesis and guide clinical intervention for asymptomatic MMDs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527319666200618150827","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T15:50:37Z","timestamp":1592495437000},"page":"306-317","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolic Adjustments by LncRNAs in Peripheral Neutrophils Partly Account for the Complete Compensation of Asymptomatic MMD Patients"],"prefix":"10.2174","volume":"19","author":[{"given":"Ziping","family":"Han","sequence":"first","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingzhi","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyou","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwen","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Tao","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Ma","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Luo","sequence":"additional","affiliation":[{"name":"Institute of Cerebrovascular Diseases Research, Department of Neurology, and Department of Neurosurgery of Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/jnnp-2011-301387","volume":"83","author":"Kleinloog R.","year":"2012","unstructured":"Kleinloog R.; Regli L.; Rinkel G.J.; Klijn C.J.; Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. J Neurol Neurosurg Psychiatry 2012,83(5),531-536","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"Scott R.M.","year":"2009","unstructured":"Scott R.M.; Smith E.R.; Moyamoya disease and moyamoya syndrome. N Engl J Med 2009,360(12),1226-1237","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5853\/jos.2015.01760","volume":"18","author":"Bang O.Y.","year":"2016","unstructured":"Bang O.Y.; Fujimura M.; Kim S.K.; The pathophysiology of moyamoya disease: an update. J Stroke 2016,18(1),12-20","journal-title":"J Stroke"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"Cecchi A.C.","year":"2014","unstructured":"Cecchi A.C.; Guo D.; Ren Z.; RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke 2014,45(11),3200-3207","journal-title":"Stroke"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.47.1","volume":"47","author":"Takagi Y.","year":"2007","unstructured":"Takagi Y.; Kikuta K.; Nozaki K.; Hashimoto N.; Histological features of middle cerebral arteries from patients treated for moyamoya disease. Neurol Med Chir (Tokyo) 2007,47(1),1-4","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1227\/01.NEU.0000192167.54627.3A","volume":"58","author":"Takagi Y.","year":"2006","unstructured":"Takagi Y.; Kikuta K.; Sadamasa N.; Nozaki K.; Hashimoto N.; Proliferative activity through extracellular signal-regulated kinase of smooth muscle cells in vascular walls of cerebral arteriovenous malformations. Neurosurgery 2006,58(4),740-748","journal-title":"Neurosurgery"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2176\/nmc.ra.2014-0305","volume":"55","author":"Kuroda S.","year":"2015","unstructured":"Kuroda S.; Group A.S.; AMORE Study Group Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurol Med Chir (Tokyo) 2015,55(3),194-198","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/01.STR.26.3.380","volume":"26","author":"Shinkawa A.","year":"1995","unstructured":"Shinkawa A.; Ueda K.; Kiyohara Y.; Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995,26(3),380-385","journal-title":"Stroke"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3171\/jns.2005.102.3.0470","volume":"102","author":"Kikuta K.","year":"2005","unstructured":"Kikuta K.; Takagi Y.; Nozaki K.; Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 2005,102(3),470-475","journal-title":"J Neurosurg"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/STROKEAHA.106.478297","volume":"38","author":"Kuroda S.","year":"2007","unstructured":"Kuroda S.; Hashimoto N.; Yoshimoto T.; Iwasaki Y.; Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 2007,38(5),1430-1435","journal-title":"Stroke"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"Derrien T.","year":"2012","unstructured":"Derrien T.; Johnson R.; Bussotti G.; The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012,22(9),1775-1789","journal-title":"Genome Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","volume":"154","author":"Ulitsky I.","year":"2013","unstructured":"Ulitsky I.; Bartel D.P.; lincRNAs: genomics, evolution, and mechanisms. Cell 2013,154(1),26-46","journal-title":"Cell"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","volume":"35","author":"Heward J.A.","year":"2014","unstructured":"Heward J.A.; Lindsay M.A.; Long non-coding RNAs in the regulation of the immune response. Trends Immunol 2014,35(9),408-419","journal-title":"Trends Immunol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"Kang H.S.","year":"2010","unstructured":"Kang H.S.; Kim J.H.; Phi J.H.; Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 2010,81(6),673-678","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.wneu.2016.05.081","volume":"93","author":"Gao F.","year":"2016","unstructured":"Gao F.; Yu L.; Zhang D.; Zhang Y.; Wang R.; Zhao J.; Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult moyamoya Disease. World Neurosurg 2016,93,111-119","journal-title":"World Neurosurg"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"42421","DOI":"10.1038\/srep42421","volume":"7","author":"Wang W.","year":"2017","unstructured":"Wang W.; Gao F.; Zhao Z.; Integrated analysis of LncRNA-mRNA co-expression profiles in patients with moyamoya disease. Sci Rep 2017,7,42421","journal-title":"Sci Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MOH.0000000000000300","volume":"24","author":"Seignez C.","year":"2017","unstructured":"Seignez C.; Phillipson M.; The multitasking neutrophils and their involvement in angiogenesis. Curr Opin Hematol 2017,24(1),3-8","journal-title":"Curr Opin Hematol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1182\/blood-2015-03-631572","volume":"126","author":"Massena S.","year":"2015","unstructured":"Massena S.; Christoffersson G.; V\u00e5gesj\u00f6 E.; Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood 2015,126(17),2016-2026","journal-title":"Blood"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1182\/blood-2012-04-421040","volume":"120","author":"Christoffersson G.","year":"2012","unstructured":"Christoffersson G.; V\u00e5gesj\u00f6 E.; Vandooren J.; VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 2012,120(23),4653-4662","journal-title":"Blood"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.it.2015.02.005","volume":"36","author":"Rivera L.B.","year":"2015","unstructured":"Rivera L.B.; Bergers G.; Intertwined regulation of angiogenesis and immunity by myeloid cells. Trends Immunol 2015,36(4),240-249","journal-title":"Trends Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1084\/jem.20120690","volume":"210","author":"Avraham-Davidi I.","year":"2013","unstructured":"Avraham-Davidi I.; Yona S.; Grunewald M.; On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells. J Exp Med 2013,210(12),2611-2625","journal-title":"J Exp Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainres.2019.05.033","volume":"1719","author":"Ma Q.","year":"2019","unstructured":"Ma Q.; Li L.; Yu B.; Circular RNA profiling of neutrophil transcriptome provides insights into asymptomatic moyamoya disease. Brain Res 2019,1719,104-112","journal-title":"Brain Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"Mercer T.R.","year":"2009","unstructured":"Mercer T.R.; Dinger M.E.; Mattick J.S.; Long non-coding RNAs: insights into functions. Nat Rev Genet 2009,10(3),155-159","journal-title":"Nat Rev Genet"},{"key":"ref=24","first-page":"1291","volume":"31","author":"Nanba R.","year":"2003","unstructured":"Nanba R.; Kuroda S.; Takeda M.; Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease. No Shinkei Geka 2003,31(12),1291-1295","journal-title":"No Shinkei Geka"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1148\/radiology.136.2.7403514","volume":"136","author":"Takahashi M.","year":"1980","unstructured":"Takahashi M.; Magnification angiography in moyamoya disease: new observations on collateral vessels. Radiology 1980,136(2),379-386","journal-title":"Radiology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.STR.14.1.104","volume":"14","author":"Suzuki J.","year":"1983","unstructured":"Suzuki J.; Kodama N.; Moyamoya disease--a review. Stroke 1983,14(1),104-109","journal-title":"Stroke"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/1871527318666190314101946","volume":"18","author":"Podsiedlik M.","year":"2019","unstructured":"Podsiedlik M.; Markowicz-Piasecka M.; Mikiciuk-Olasik E.; Sikora J.; The associations between central nervous system diseases and haemostatic disorders. CNS Neurol Disord Drug Targets 2019,18(4),307-316","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2174\/1871527317666180827111152","volume":"17","author":"Mohammadi F.","year":"2018","unstructured":"Mohammadi F.; Nezafat N.; Negahdaripour M.; Neuroprotective effects of heat shock protein 70. CNS Neurol Disord Drug Targets 2018,17(10),736-742","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1871527317666180612125843","volume":"17","author":"Wang S.","year":"2018","unstructured":"Wang S.; Ma F.; Huang L.; Dl-3-n-Butylphthalide (NBP): a promising therapeutic agent for ischemic stroke. CNS Neurol Disord Drug Targets 2018,17(5),338-347","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2174\/1871527317666180502110205","volume":"17","author":"Gong Z.","year":"2018","unstructured":"Gong Z.; Pan J.; Li X.; Wang H.; He L.; Peng Y.; Hydroxysafflor yellow A reprograms TLR9 signalling pathway in ischaemic cortex after cerebral ischaemia and reperfusion. CNS Neurol Disord Drug Targets 2018,17(5),370-382","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1871527317666180425124340","volume":"17","author":"Catalin B.","year":"2018","unstructured":"Catalin B.; Rogoveanu O.C.; Pirici I.; Cerebrolysin and aquaporin 4 inhibition improve pathological and motor recovery after ischemic stroke. CNS Neurol Disord Drug Targets 2018,17(4),299-308","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2174\/1871527317666180724143258","volume":"17","author":"Arshad N.","year":"2018","unstructured":"Arshad N.; Lin T.S.; Yahaya M.F.; Metabolic syndrome and its effect on the brain: possible mechanism. CNS Neurol Disord Drug Targets 2018,17(8),595-603","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/bib\/bbv031","volume":"17","author":"Ferr\u00e8 F.","year":"2016","unstructured":"Ferr\u00e8 F.; Colantoni A.; Helmer-Citterich M.; Revealing protein-lncRNA interaction. Brief Bioinform 2016,17(1),106-116","journal-title":"Brief Bioinform"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s12035-016-9754-0","volume":"54","author":"Xu J.","year":"2017","unstructured":"Xu J.; Zhang F.; Gao C.; Microarray analysis of lncRNA and mRNA expression profiles in patients with neuromyelitis optica. Mol Neurobiol 2017,54(3),2201-2208","journal-title":"Mol Neurobiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.33594\/000000046","volume":"52","author":"Wang D.","year":"2019","unstructured":"Wang D.; Gu C.; Liu M.; Liu G.; Liu H.; Wang Y.; Analysis of long noncoding RNA expression profile in human pulmonary microvascular endothelial cells exposed to lipopolysaccharide. Cell Physiol Biochem 2019,52(4),653-667","journal-title":"Cell Physiol Biochem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/1871527318666190204102604","volume":"18","author":"Li L.","year":"2019","unstructured":"Li L.; Wang P.; Zhao H.; Luo Y.; Noncoding RNAs and intracerebral hemorrhage. CNS Neurol Disord Drug Targets 2019,18(3),205-211","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/1871527318666190204104629","volume":"18","author":"Forouzanfar F.","year":"2019","unstructured":"Forouzanfar F.; Shojapour M.; Asgharzade S.; Amini E.; Causes and consequences of MicroRNA dysregulation following cerebral ischemia-reperfusion injury. CNS Neurol Disord Drug Targets 2019,18(3),212-221","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11011-017-9965-8","volume":"32","author":"Chen Y.","year":"2017","unstructured":"Chen Y.; Zhou J.; LncRNAs: macromolecules with big roles in neurobiology and neurological diseases. Metab Brain Dis 2017,32(2),281-291","journal-title":"Metab Brain Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","volume":"88","author":"Kubes P.","year":"1991","unstructured":"Kubes P.; Suzuki M.; Granger D.N.; Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991,88(11),4651-4655","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/shk.0b013e31802f0190","volume":"28","author":"Yeh C.L.","year":"2007","unstructured":"Yeh C.L.; Hsu C.S.; Chen S.C.; Hou Y.C.; Chiu W.C.; Yeh S.L.; Effect of arginine on cellular adhesion molecule expression and leukocyte transmigration in endothelial cells stimulated by biological fluid from surgical patients. Shock 2007,28(1),39-44","journal-title":"Shock"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1164\/ajrccm\/146.5_Pt_2.S45","volume":"146","author":"Williams T.J.","year":"1992","unstructured":"Williams T.J.; Hellewell P.G.; Endothelial cell biology. Adhesion molecules involved in the microvascular inflammatory response. Am Rev Respir Dis 1992,146(5 Pt 2),S45-S50","journal-title":"Am Rev Respir Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/STROKEAHA.119.024689","volume":"50","author":"Sato Y.","year":"2019","unstructured":"Sato Y.; Kazumata K.; Nakatani E.; Houkin K.; Kanatani Y.; Characteristics of moyamoya disease based on national registry data in Japan. Stroke 2019,50(8),1973-1980","journal-title":"Stroke"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/ped.13499","volume":"60","author":"Hoshino S.","year":"2018","unstructured":"Hoshino S.; Tsuda E.; Miyazaki A.; Vasospastic angina and asymptomatic moyamoya disease in a 14-year-old girl. Pediatr Int (Roma) 2018,60(3),296-297","journal-title":"Pediatr Int (Roma)"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM198103263041306","volume":"304","author":"Miller D.","year":"1981","unstructured":"Miller D.; Waters D.D.; Warnica W.; Szlachcic J.; Kreeft J.; Th\u00e9roux P.; Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981,304(13),763-766","journal-title":"N Engl J Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13256-015-0537-4","volume":"9","author":"Choi W.","year":"2015","unstructured":"Choi W.; Kim Y.N.; Kim K.H.; Variant angina in moyamoya disease--a correlative etiology and different presentation: a case report. J Med Case Reports 2015,9,86","journal-title":"J Med Case Reports"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2176\/nmc.41.37","volume":"41","author":"Komiyama M.","year":"2001","unstructured":"Komiyama M.; Nishikawa M.; Yasui T.; Otsuka M.; Haze K.; Moyamoya disease and coronary artery disease--case report. Neurol Med Chir (Tokyo) 2001,41(1),37-41","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"Te Riet L.","year":"2015","unstructured":"Te Riet L.; van Esch J.H.; Roks A.J.; van den Meiracker A.H.; Danser A.H.; Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res 2015,116(6),960-975","journal-title":"Circ Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.ijcard.2014.07.232","volume":"176","author":"Lee M.Y.","year":"2014","unstructured":"Lee M.Y.; Lai W.T.; Low plasma renin level is associated with the occurrence of angiographic radial artery spasm in patients undergoing transradial coronary procedures. Int J Cardiol 2014,176(3),1195-1197","journal-title":"Int J Cardiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","year":"2012","unstructured":"Research committee on the pathology and treatment of spontaneous occlusion of the Circle of Willis, health labour sciences research grant for research on measures for infractable diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the Circle of Willis). Neurol Med Chir (Tokyo) 2012,52,245-266","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","volume":"27","author":"Oki K.","year":"2018","unstructured":"Oki K.; Katsumata M.; Izawa Y.; Takahashi S.; Suzuki N.; Houkin K.; Research committee on spontaneous occlusion of Circle of Willis (moyamoya disease). Trends of antiplatelet therapy for the management of moyamoya disease in Japan: results of a nationwide survey. J Stroke Cerebrovasc Dis 2018,27(12),3605-3612","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/182918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182918\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/182918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T20:18:28Z","timestamp":1614457108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182918\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527319666200618150827","relation":{},"ISSN":["1871-5273"],"issn-type":[{"type":"print","value":"1871-5273"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}